HonCode

Go Back   HER2 Support Group Forums > her2group
Register Gallery FAQ Members List Calendar Today's Posts

 
 
Thread Tools Display Modes
Prev Previous Post   Next Post Next
Old 01-10-2013, 05:10 PM   #1
KDR
Senior Member
 
KDR's Avatar
 
Join Date: Aug 2010
Location: New York, New York
Posts: 1,580
Thumbs up Thank You, St. Therese, Little Flower of Jesus

Tender of the Gardens of Heaven, for all of your divine intervention on my behalf. I promise to spread the word of your work.



Treatment Facility: Memorial Sloan Kettering Cancer Center (NYC); World Trade Center Survivor (56th Floor/North Tower);
Dxd: June 2010, liver mets. ER-/PR+10%; HER2+++.
July 2010: Begin Taxol/Herceptin.
January 2011: NED
April 2011: Progression in liver only. Other previous affected areas eradicated. Discontinue Taxol/Herceptin after 32 infusions.
May 2011: Brain MRI: clear.
May 2011: Begin Tykerb daily, Xeloda twice per day for one week on, one week off, and Herceptin.
June-October 2011: CEA in normal range. PET/CT stable; no new lesions.
November 2011: Progression in liver. Previous tumors remain eradicated.
December 2011: Begin trial: 09-093 Taxol, MCC-DM1 (T-DM1), Pertuzumab. Brain MRI: clear.
January 2012: NED. Liver mets eradicated.
March 2012: NED. Taxol removed from regimen. Continue Protocol of T-DM1 and Pertuzumab alone.
May 2012: NED.
June 2012: Brain MRI: clear.
June 2012: NED.
August 2012: NED.
September 2012: NED.
October 2012: NED.
November 2012: NED.
December 2012: NED. 09-093 trial completed; continue on extended study. CT, bone scan and brain MRI clear. Forever, please.


Karen
KDR is offline   Reply With Quote
 


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Forum Jump


All times are GMT -7. The time now is 04:18 PM.


Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021
free webpage hit counter